Needham & Company LLC Lowers Vital Farms (NASDAQ:VITL) Price Target to $20.00

Vital Farms (NASDAQ:VITL) had its price objective cut by equities research analysts at Needham & Company LLC from $35.00 to $20.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s target price indicates a potential upside of 52.21% from the stock’s previous close.

Several other research analysts have also weighed in on the company. TD Cowen reissued a “buy” rating on shares of Vital Farms in a research report on Tuesday, January 20th. Zacks Research cut Vital Farms from a “hold” rating to a “strong sell” rating in a research note on Monday, March 2nd. Morgan Stanley reiterated an “equal weight” rating and issued a $24.00 target price (down from $45.00) on shares of Vital Farms in a report on Friday, February 27th. Benchmark lowered shares of Vital Farms from a “buy” rating to a “hold” rating in a research report on Thursday, February 26th. Finally, Telsey Advisory Group decreased their price target on shares of Vital Farms from $35.00 to $26.00 and set an “outperform” rating for the company in a report on Friday. Nine equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $42.82.

Vital Farms Trading Up 1.0%

NASDAQ VITL opened at $13.14 on Friday. The firm’s 50 day moving average price is $22.83 and its two-hundred day moving average price is $31.40. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.61 and a current ratio of 2.16. Vital Farms has a twelve month low of $12.80 and a twelve month high of $53.13. The stock has a market cap of $588.67 million, a price-to-earnings ratio of 9.13 and a beta of 1.14.

Vital Farms (NASDAQ:VITL) last released its earnings results on Thursday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.03). The business had revenue of $213.55 million during the quarter, compared to analysts’ expectations of $212.83 million. Vital Farms had a net margin of 8.73% and a return on equity of 20.69%. Vital Farms’s revenue for the quarter was up 28.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.23 EPS. Equities analysts anticipate that Vital Farms will post 1.11 EPS for the current year.

Insiders Place Their Bets

In other news, major shareholder Matthew Ohayer sold 20,000 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $20.33, for a total transaction of $406,600.00. Following the completion of the sale, the insider directly owned 6,321,190 shares of the company’s stock, valued at $128,509,792.70. This trade represents a 0.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Karl Khoury purchased 5,000 shares of the business’s stock in a transaction dated Monday, March 9th. The shares were purchased at an average cost of $18.45 per share, with a total value of $92,250.00. Following the completion of the purchase, the director directly owned 119,789 shares in the company, valued at approximately $2,210,107.05. This represents a 4.36% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders have sold 65,000 shares of company stock valued at $1,736,050. Insiders own 21.30% of the company’s stock.

Hedge Funds Weigh In On Vital Farms

A number of hedge funds have recently added to or reduced their stakes in VITL. Royal Bank of Canada raised its position in Vital Farms by 89.2% during the first quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock valued at $591,000 after acquiring an additional 9,136 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Vital Farms by 5.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock worth $611,000 after acquiring an additional 1,108 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Vital Farms by 3.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock worth $12,658,000 after purchasing an additional 13,397 shares during the last quarter. Woodline Partners LP acquired a new position in shares of Vital Farms during the 1st quarter worth $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Vital Farms by 1.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock valued at $2,739,000 after purchasing an additional 1,198 shares in the last quarter. Institutional investors and hedge funds own 98.59% of the company’s stock.

Trending Headlines about Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Two sell‑side firms cut price targets but kept bullish ratings (Needham lowered its target to $20 with a “buy”; Telsey cut its target to $26 with an “outperform”), signaling continued analyst conviction that there is upside from current levels. Benzinga note on price target changes
• Neutral Sentiment: Balance‑sheet and valuation context: VITL trades at a low P/E (~9x) with minimal debt (debt/equity ~0.01), which can support recovery if operational trends improve. (Background market data)
• Negative Sentiment: Multiple securities class‑action filings and investor notices were announced this week (Rosen Law Firm, Robbins LLP and related alerts), alleging Vital Farms made materially misleading statements and seeking damages for purchases from May 8, 2025 through Feb 26, 2026; Rosen’s notice sets a lead‑plaintiff motion deadline of May 26, 2026 — a clear near‑term legal overhang. Rosen Law Firm filing Business Wire Rosen alert Robbins LLP notice
• Negative Sentiment: Recent price action shows notable weakness (a larger drop was reported on 3/26), underscoring market sensitivity to the legal headlines and recent operating/earnings signals. Zacks price‑action note

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.